stocks logo

TSVT

2Seventy Bio Inc
$
0.000
-5(-100.000%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
193.28M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
51.41M
EV
95.77M
EV/OCF(TTM)
--
P/S(TTM)
5.51
2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). Abecma is its B cell maturation antigen (BCMA)-targeted CAR T cell therapy for multiple myeloma, in collaboration with their partner Bristol Myers Squibb (BMS). ABECMA is a BCMA-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Abecma uses a lentiviral vector (LVV), to deliver a chimeric antigen receptor (CAR), with the potential to program a patient’s own T cells to recognize the plasma cell specific BCMA, protein on the cell surface.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
18.90M
+545.93%
--
--
16.50M
+21.94%
--
--
13.43M
+49.79%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for 2seventy bio, Inc. (TSVT) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 0.40%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+0.40%
In Past 3 Month
2 Analyst Rating
up Image0
Wall Street analysts forecast TSVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TSVT is 5.00 USD with a low forecast of 5.00 USD and a high forecast of 5.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
up Image0
Current: 0
sliders
Low
5.00
Averages
5.00
High
5.00
Morgan Stanley
Matthew Harrison
Hold
Maintains
$6 → $5
2025-03-14
Reason
Morgan Stanley lowered the firm's price target on 2seventy Bio (TSVT) to $5 from $6 and keeps an Equal Weight rating on the shares following 2Seventy Bio's recent announcement to be acquired by Bristol Myers (BMY). The firm expects an on-time transaction close in Q2 at the proposed transaction price.
Leerink Partners
Daina Graybosch
Buy
to
Hold
Downgrades
$9 → $5
2025-03-11
Reason
Morgan Stanley
Matthew Harrison
Hold
Maintains
$7 → $6
2024-07-29
Reason

Valuation Metrics

The current forward P/E ratio for 2Seventy Bio Inc (TSVT.O) is -23.76, compared to its 5-year average forward P/E of -3.54. For a more detailed relative valuation and DCF analysis to assess 2Seventy Bio Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.54
Current PE
-23.76
Overvalued PE
-0.74
Undervalued PE
-6.35

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-2.56
Current EV/EBITDA
-8.00
Overvalued EV/EBITDA
-1.07
Undervalued EV/EBITDA
-4.04

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
4.76
Current PS
4.12
Overvalued PS
7.24
Undervalued PS
2.28

Financials

Annual
Quarterly
FY2025Q1
YoY :
+84.46%
22.94M
Total Revenue
FY2025Q1
YoY :
-94.81%
-2.46M
Operating Profit
FY2025Q1
YoY :
-100.92%
482.00K
Net Income after Tax
FY2025Q1
YoY :
-100.99%
0.01
EPS - Diluted
FY2025Q1
YoY :
-74.17%
-10.97M
Free Cash Flow
FY2025Q1
YoY :
+5.20%
77.54
Gross Profit Margin - %
FY2025Q1
YoY :
-52.53%
-112.04
FCF Margin - %
FY2025Q1
YoY :
-100.50%
2.10
Net Margin - %

Trading Trends

Insider
Insiders areSelling! The selling amount has increased 21485.15% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
80.1M
USD
5
6-9
Months
378.5K
USD
10
0-12
Months
33.8K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 870.15% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
2.0M
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
3
1.3M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

TSVT News & Events

Events Timeline

2025-03-25 (ET)
2025-03-25
16:06:48
2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year
select
2024-12-03 (ET)
2024-12-03
04:10:26
Regeneron pays $1M milestone payment to Medigene
select
2024-11-12 (ET)
2024-11-12
06:39:36
2seventy Bio reports Q3 EPS (19c), consensus (24c)
select
Sign Up For More Events

News

7.0
04-16PRnewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BHLB, TSVT, RDFN on Behalf of Shareholders
9.0
04-01NASDAQ.COM
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
3.0
03-23NASDAQ.COM
$TSVT Earnings Preview: Recent $TSVT Insider Trading, Hedge Fund Activity, and More
Sign Up For More News

FAQ

arrow icon

What is 2Seventy Bio Inc (TSVT) stock price today?

The current price of TSVT is 0 USD — it has increased 0.2 % in the last trading day.

arrow icon

What is 2Seventy Bio Inc (TSVT)'s business?

arrow icon

What is the price predicton of TSVT Stock?

arrow icon

What is 2Seventy Bio Inc (TSVT)'s revenue for the last quarter?

arrow icon

What is 2Seventy Bio Inc (TSVT)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for 2Seventy Bio Inc (TSVT)'s fundamentals?

arrow icon

How many employees does 2Seventy Bio Inc (TSVT). have?

arrow icon

What is 2Seventy Bio Inc (TSVT) market cap?